Knockdown of CDK2AP1 significantly inhibits glioma cell proliferation and induces cell cycle arrest in G0/G1 phase, thus speculating that CDK2AP1 may be an anti-apoptotic molecular switch in glioma development. The gene discussed is CDK2AP1; the disease is central nervous system cancer.